Cargando…
BPI-ANCA and Long-Term Prognosis among 46 Adult CF Patients: A Prospective 10-Year Follow-Up Study
Introduction. Anti-neutrophil cytoplasmic antibodies specific for bactericidal/permeability-increasing protein (BPI-ANCA) are frequent in CF patients and mainly develop in response to infection with Pseudomonas aeruginosa. It is not known to what extent BPI-ANCA correlates to prognosis. Objectives....
Autores principales: | Lindberg, Ulrika, Carlsson, Malin, Löfdahl, Claes-Göran, Segelmark, Mårten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546553/ https://www.ncbi.nlm.nih.gov/pubmed/23346184 http://dx.doi.org/10.1155/2012/370107 |
Ejemplares similares
-
BPI-ANCA Provides Additional Clinical Information to Anti-Pseudomonas Serology: Results from a Cohort of 117 Swedish Cystic Fibrosis Patients
por: Lindberg, Ulrika, et al.
Publicado: (2015) -
The Pathogenicity of BPI-ANCA in a Patient With Systemic Vasculitis
por: Takeda, Sayo, et al.
Publicado: (2019) -
Neutrophil Extracellular Traps in ANCA-Associated Vasculitis
por: Söderberg, Daniel, et al.
Publicado: (2016) -
Clinical significance of BPI-ANCA in patients with cystic fibrosis: a single center prospective study
por: Iwuji, Kenneth, et al.
Publicado: (2023) -
Clinical significance of BPI‐ANCA detecting in COPD patients with Pseudomonas aeruginosa colonization
por: Tian, Yongjian, et al.
Publicado: (2019)